Optimi Health ships psilocybin capsules to Australia in third export
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall St set for lower open as oil gains on Mideast uncertainty, eyes on Trump-Xi talks
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- Plug Power COO resigns to join another company
- Wall Street ends down as oil prices, Treasury yields rise
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Anthropic's Claude AI identifies novel enzyme system in DNA search
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
June 29, 2026 9:00 AM EDTOptimis 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.
The export marks Optimis third commercial shipment since launching the 5mg psilocybin capsules in September 2025.
VANCOUVER, British Columbia, June 29, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the Company or... More
